Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPOX | P50336 | 16/20 | 0.64 |
| ▸ | MEN1 | O00255 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.64 |
| ▸ | PGK1 | P00558 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL39055 | 0.99 | PPOX (0.65) | PPOXMEN1KMT2ATDP1NR1I2 | |
| SCHEMBL29635318 | 0.99 | PPOX (0.65) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Acetone SCHEMBL532802 | 0.95 | PPOX (0.61) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Isopropylamine SCHEMBL19641800 | 0.94 | PPOX (0.66) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Oxadiazon SCHEMBL4659772 | 0.92 | PPOX (0.79) | PPOXMEN1KMT2ATDP1NR1I2 | |
| SCHEMBL20425261 | 0.91 | PPOX (0.57) | PPOXMEN1KMT2ATDP1NR1I2 | |
| SCHEMBL14505698 | 0.90 | PPOX (0.57) | PPOXMEN1KMT2ATDP1NR1I2 | |
| SCHEMBL10437860 | 0.89 | PPOX (0.53) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Oxadiargyl SCHEMBL29370865 | 0.88 | PPOX (0.65) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Simazine SCHEMBL7579114 | 0.87 | PPOX (0.52) | PPOXMEN1KMT2ATDP1NR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112672998-B | Co-crystal form A of oxaagolide and pyrimethamine, and preparation method and application thereof | 深圳仁泰医药科技有限公司 | 2022-06-21 | — | — | CN | claimed |
| CN-112672998-A | Co-crystal form A of oxaagolide and pyrimethamine, and preparation method and application thereof | 深圳仁泰医药科技有限公司 | 2021-04-16 | — | — | CN | claimed |
| CN-115515592-A | Methods of administering oxaagolide | 艾伯维公司 | 2022-12-23 | — | — | CN | disclosed |
| CN-115177595-A | Oxagolide sodium tablet and preparation method thereof | 金陵药业股份有限公司 | 2022-10-14 | — | — | CN | disclosed |
| CN-112679442-B | Preparation method of oxaagolide sodium | 浙江乐普药业股份有限公司 | 2022-09-06 | — | — | CN | disclosed |
| CN-112672998-B | Co-crystal form A of oxaagolide and pyrimethamine, and preparation method and application thereof | 深圳仁泰医药科技有限公司 | 2022-06-21 | — | — | CN | disclosed |
| CN-113912552-A | Preparation method of amorphous form of oxalagogri sodium | 成都苑东生物制药股份有限公司 | 2022-01-11 | — | — | CN | disclosed |
| CN-112679442-A | Preparation method of oxaagolide sodium | 浙江乐普药业股份有限公司 | 2021-04-20 | — | — | CN | disclosed |
| CN-112672998-A | Co-crystal form A of oxaagolide and pyrimethamine, and preparation method and application thereof | 深圳仁泰医药科技有限公司 | 2021-04-16 | — | — | CN | disclosed |
| CN-111499581-A | Oxagolide sodium impurity, preparation method and application thereof | 上海博悦生物科技有限公司 | 2020-08-07 | — | — | CN | disclosed |